Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Bahram G Kermani"'
Autor:
Richard B Lanman, Stefanie A Mortimer, Oliver A Zill, Dragan Sebisanovic, Rene Lopez, Sibel Blau, Eric A Collisson, Stephen G Divers, Dave S B Hoon, E Scott Kopetz, Jeeyun Lee, Petros G Nikolinakos, Arthur M Baca, Bahram G Kermani, Helmy Eltoukhy, AmirAli Talasaz
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140712 (2015)
Next-generation sequencing of cell-free circulating solid tumor DNA addresses two challenges in contemporary cancer care. First this method of massively parallel and deep sequencing enables assessment of a comprehensive panel of genomic targets from
Externí odkaz:
https://doaj.org/article/133fc4af39b34633abd205b896147ca3
Autor:
Bahram G. Kermani
Publikováno v:
Cancer Research. 82:5932-5932
Breast cancer screening is the first line-of-defense in detecting this disease early, and consequently changing its outcomes, dramatically. We introduce Crystalogram as a novel, radiation-free, blood-based, breast cancer screening tool, for asymptoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c24a6af4c28726e9a7e1a11206ab95fa
https://doi.org/10.1158/1538-7445.am2022-5932
https://doi.org/10.1158/1538-7445.am2022-5932
Autor:
Bahram G Kermani
Publikováno v:
Personalized Medicine. 13:287-290
Crystal Genetics, Inc. is an early-stage genetic test company, focused on achieving the highest possible clinical-grade accuracy and comprehensiveness for detecting germline (e.g., in hereditary cancer) and somatic (e.g., in early cancer detection) m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d557a58300d456610804764dd165b6bf
https://doi.org/10.2217/pme-2016-0036
https://doi.org/10.2217/pme-2016-0036
Publikováno v:
Cancer Research. 79:1625-1625
In the recent years, early detection of cancer using next-generation sequencing (NGS) has been en vogue, due to its potential to drastically improve the survival rate of cancer patients. Liquid biopsy is often viewed as the modus operandi for early d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d96bba070f364eb766e1f87ed9bca0cf
https://doi.org/10.1158/1538-7445.am2019-1625
https://doi.org/10.1158/1538-7445.am2019-1625
Publikováno v:
Cancer Research. 78:4280-4280
In the recent years, wide targeted gene panels have gained popularity, due to their ability to interrogate many genes at the same time. In cancer, particularly, there is a set of ~600 genes known as Cancer Gene Census for which mutations have been ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e06d3f32bda53fd964434a20cc8763c
https://doi.org/10.1158/1538-7445.am2018-4280
https://doi.org/10.1158/1538-7445.am2018-4280
Autor:
Robert Hartlage, Brock A. Peters, Igor Nazarenko, Jonathan Baccash, Calvin Kong, Vitali Karpinchyk, Andres Fernandez, Abraham M. Rosenbaum, Ryan J. Cedeno, Paolo Carnevali, Celeste E. McBride, Norman L. Burns, Shaunak Roy, Karen W. Shannon, George M. Church, Snezana Drmanac, Daniel F. Chernikoff, Radoje Drmanac, Geoffrey B. Nilsen, Claudia Richter, Coleen R. Hacker, Jay Shafto, William C. Banyai, Kaliprasad Pothuraju, Helena Perazich, Bruce L. Martin, Dennis G. Ballinger, Benjamin Curson, Linsu Chen, Brian Hauser, Steve Huang, Alexander Wait Zaranek, Anushka Brownley, Dylan Vu, Matt Morenzoni, Andrew B. Sparks, Matthew J. Callow, Alex Cheung, Clifford Reid, Adam P. Borcherding, George Yeung, Xiaodi Wu, Catherine Le, Tom Landers, Aaron L. Halpern, Bahram G. Kermani, Kimberly Perry, Arnold R. Oliphant, Mark Koenig, Charit L. Pethiyagoda, Michel Sun, Joseph V. Thakuria, Conrad G. Sheppy, Anne Tran, Robert E. Morey, Fredrik A. Dahl, Krishna Pant, Karl Mutch, Bryan Staker, Joe Peterson, Jessica Ebert, Yuan Jiang, Jia Liu, Razvan Chirita, Uladzislau Sharanhovich
Publikováno v:
Science. 327:78-81
Toward $1000 Genomes The ability to generate human genome sequence data that is complete, accurate, and inexpensive is a necessary prerequisite to perform genome-wide disease association studies. Drmanac et al. (p. 78 , published online 5 November) p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc5b869194526e702f24446172ea13f
https://doi.org/10.1126/science.1181498
https://doi.org/10.1126/science.1181498
Autor:
Eric A. Collisson, Stefanie Mortimer, Amir Ali Talasaz, Rene Lopez, Petros Nikolinakos, Bahram G. Kermani, Dragan Sebisanovic, Helmy Eltoukhy, Arthur Baca, Dave S.B. Hoon, E. Scott Kopetz, Stephen G. Divers, Oliver A. Zill, Richard B. Lanman, Jeeyun Lee, Sibel Blau
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140712 (2015)
PLoS ONE
PLoS ONE
Next-generation sequencing of cell-free circulating solid tumor DNA addresses two challenges in contemporary cancer care. First this method of massively parallel and deep sequencing enables assessment of a comprehensive panel of genomic targets from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d5bbfecfe03d267ed1e870027b1fde
https://doaj.org/article/133fc4af39b34633abd205b896147ca3
https://doaj.org/article/133fc4af39b34633abd205b896147ca3
Autor:
Dragan Sebisanovic, Devi M. Gadde, Eric A. Collisson, Reza Bayat Mokhtari, Helmy Eltoukhy, AmirAli Talasaz, Bahram G. Kermani, Heena Patel, Rene Lopez, Richard B. Lanman, Somayeh Bakhtiari, Stefanie Mortimer, Maria M. Vidamo
Publikováno v:
Cancer Research. 75:2403-2403
Background: Genomic alterations of metastatic cancers may be discordant with alterations in primary tumors due to continuous evolution of disease and tumor heterogeneity. Current NGS approaches based on tissue biopsies can fail to capture a complete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57541a1439370cf40727cc147e043b8a
https://doi.org/10.1158/1538-7445.am2015-2403
https://doi.org/10.1158/1538-7445.am2015-2403
Autor:
Igor A. Kozlov, Bahram G. Kermani, Peter C. Melnyk, David L. Barker, Chanfeng Zhao, John P. Hachmann, Michal Lebl
Publikováno v:
Journal of Chromatographic Science; Apr2007, Vol. 45 Issue 4, p207-211, 5p